Robert E. Coleman, MD, FRCP
Cancer Research Centre at Weston Park Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert E. Coleman, MD, FRCP as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:26 UTC. Open this list on ClinicalTrials.gov
- N/ANCT00458796 · Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the BoneUniversity of Leeds · terminated · Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer · study chair
- Ph3NCT00072020 · Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast CancerUniversity of Sheffield · unknown · Breast Cancer, Metastatic Cancer · unknown
- Ph2NCT00005980 · Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Breast Cancer · study chair
- Ph3NCT00045032 · Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast CancerHoffmann-La Roche · completed · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.